Literature DB >> 8947815

The significance of elevated progesterone at the time of administration of human chorionic gonadotropin may be related to luteal support.

K F Miller1, E J Behnke, R L Arciaga, J M Goldberg, N W Chin, S G Awadalla.   

Abstract

PURPOSE: Our purpose was to determine if the progesterone concentration on the day of HCG administration is associated with the establishment of pregnancy in IVF patients.
METHODS: Concentrations of progesterone on the day of hCG were examined retrospectively in 293 patients with ovarian hyperstimulation induced by GnRH agonist with hMG and/or FSH. Patients were grouped based on progesterone concentration: < 0.9, 0.9 to < 1.2, 1.2 to < 1.5, and > or = 1.5 ng/ml. Oocytes recovered, fertilization rate, and pregnancy rate were compared among groups.
RESULTS: Patients with a higher concentration of progesterone had increased concentrations of estradiol and greater numbers of oocytes retrieved. No differences were found for fertilization rate, polyploid fertilization, or pregnancy rate. It was noted that there was an association between the type of luteal support and the effect of high preovulatory progesterone on pregnancy rate.
CONCLUSIONS: These data suggest that oocytes and embryos derived from patients with high preovulatory progesterone are not of a reduced quality. The association of high progesterone concentrations with a reduced rate of pregnancy varied with the type of luteal support.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947815     DOI: 10.1007/bf02066420

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  10 in total

1.  Effect of preovulatory progesterone administration on the endometrial maturation and implantation rate after in vitro fertilization and embryo transfer.

Authors:  I Ben-Nun; Y Ghetler; R Jaffe; A Siegal; H Kaneti; M Fejgin
Journal:  Fertil Steril       Date:  1990-02       Impact factor: 7.329

2.  Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer.

Authors:  M Bustillo; J J Stern; C B Coulam
Journal:  Hum Reprod       Date:  1995-11       Impact factor: 6.918

3.  Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome.

Authors:  M C Edelstein; H J Seltman; B J Cox; S M Robinson; R A Shaw; S J Muasher
Journal:  Fertil Steril       Date:  1990-11       Impact factor: 7.329

4.  Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer.

Authors:  R Fanchin; D de Ziegler; J Taieb; A Hazout; R Frydman
Journal:  Fertil Steril       Date:  1993-05       Impact factor: 7.329

5.  Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality.

Authors:  G E Hofmann; F Bentzien; P A Bergh; G J Garrisi; M C Williams; I Guzman; D Navot
Journal:  Fertil Steril       Date:  1993-10       Impact factor: 7.329

6.  Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate.

Authors:  W Schoolcraft; E Sinton; T Schlenker; D Huynh; F Hamilton; D R Meldrum
Journal:  Fertil Steril       Date:  1991-03       Impact factor: 7.329

7.  Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization.

Authors:  R S Legro; B A Ary; R J Paulson; F Z Stanczyk; M V Sauer
Journal:  Hum Reprod       Date:  1993-09       Impact factor: 6.918

8.  Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles.

Authors:  C R Givens; E D Schriock; P V Dandekar; M C Martin
Journal:  Fertil Steril       Date:  1994-11       Impact factor: 7.329

9.  Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins.

Authors:  K M Silverberg; W N Burns; D L Olive; R M Riehl; R S Schenken
Journal:  J Clin Endocrinol Metab       Date:  1991-10       Impact factor: 5.958

10.  Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in vitro fertilization cycles do not adversely affect embryo quality.

Authors:  K M Silverberg; M Martin; D L Olive; W N Burns; R S Schenken
Journal:  Fertil Steril       Date:  1994-03       Impact factor: 7.329

  10 in total
  5 in total

1.  Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update.

Authors:  Aboubakr M Elnashar
Journal:  J Assist Reprod Genet       Date:  2010-02-23       Impact factor: 3.412

Review 2.  The curious case of premature luteinization.

Authors:  Apostolos Kaponis; Elpiniki Chronopoulou; George Decavalas
Journal:  J Assist Reprod Genet       Date:  2018-07-26       Impact factor: 3.412

3.  Elevated progesterone-to-estradiol ratio versus serum progesterone alone for predicting poor cycle outcome with in vitro fertilization.

Authors:  Martin D Keltz; Daniel E Stein; Inna Berin; Josh Skorupski
Journal:  J Reprod Med       Date:  2012 Jan-Feb       Impact factor: 0.142

4.  Premature progesterone rise at human chorionic gonadotropin triggering day has no correlation with intracytoplasmic sperm injection outcome.

Authors:  Nasrin Saharkhiz; Saghar Salehpour; Mahboobeh Tavasoli; Ali Aghighi
Journal:  Iran J Reprod Med       Date:  2015-02

Review 5.  Association Between Progesterone Elevation on the Day of Human Chronic Gonadotropin Trigger and Pregnancy Outcomes After Fresh Embryo Transfer in In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles.

Authors:  Sandro C Esteves; Gautam Khastgir; Jatin Shah; Kshitiz Murdia; Shweta Mittal Gupta; Durga G Rao; Soumyaroop Dash; Kundan Ingale; Milind Patil; Kunji Moideen; Priti Thakor; Pavitra Dewda
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-26       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.